scispace - formally typeset
S

Siddhartha Dutta

Researcher at All India Institute of Medical Sciences

Publications -  64
Citations -  765

Siddhartha Dutta is an academic researcher from All India Institute of Medical Sciences. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 41 publications receiving 166 citations.

Papers
More filters
Journal ArticleDOI

Household Transmission of COVID-19: A Cross-Sectional Study

TL;DR: One in four family members got infected with COVID-19, they were majority males and in the working age group, which indicates some other factors may be responsible for household transmission than these factors.
Journal ArticleDOI

Euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors: A systematic review and quantitative analysis

TL;DR: EuDKA is commonly seen in middle-aged female, T2DM patients taking SGLT2 inhibitors along with metformin, and the risk of DKA in patients receiving SGLt2 inhibitors increases by 3.7 times than the other medication.
Posted ContentDOI

Serious adverse events reported from the COVID-19 vaccines: A descriptive study based on WHO database

TL;DR: In this article, the Serious Adverse Events (SAEs) associated with various COVID-19 vaccines reported in the WHO database (VigiBase®) were assessed to assess the reported SAEs linked to various CoVID-2019 vaccines.
Journal ArticleDOI

Opinion of patients seeking primary care regarding prescription of generic drugs: A cross-sectional study

TL;DR: Awareness about the generic drugs was low among the patients visiting the primary care physician and the young age and primary and secondary education levels were significantly associated with the awareness regarding generics.
Journal ArticleDOI

Demand of COVID-19 medicines without prescription among community pharmacies in Jodhpur, India: Findings and implications

TL;DR: This study was unable to detect a significant increase in sales of antimicrobials, which is encouraging, but there was an increase in the demand for COVID-19 medications without prescription.